Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontransmembrane transporter activity

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A PIEZO2 SLC22A8 SLC16A5 SLC6A16 SLC25A13 KCNK15 SLC22A11 KCNK3 MPEG1 SLC30A3 KCNK9 ANO3 AQP9 RYR3 TFRC

1.96e-1011806220GO:0022857
GeneOntologyMolecularFunctioninorganic molecular entity transmembrane transporter activity

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A SLC22A8 SLC25A13 KCNK15 SLC22A11 KCNK3 SLC30A3 KCNK9 ANO3 AQP9 RYR3 TFRC

8.49e-107586216GO:0015318
GeneOntologyMolecularFunctiontransporter activity

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A PIEZO2 SLC22A8 SLC16A5 SLC6A16 SLC25A13 KCNK15 SLC22A11 KCNK3 MPEG1 SLC30A3 KCNK9 ANO3 AQP9 RYR3 TFRC

9.22e-1012896220GO:0005215
GeneOntologyMolecularFunctionmonoatomic cation transmembrane transporter activity

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A PIEZO2 SLC25A13 KCNK15 KCNK3 SLC30A3 KCNK9 RYR3 TFRC

1.00e-076646213GO:0008324
GeneOntologyMolecularFunctionmonoatomic ion transmembrane transporter activity

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A PIEZO2 SLC25A13 KCNK15 KCNK3 SLC30A3 KCNK9 ANO3 RYR3 TFRC

1.07e-077936214GO:0015075
GeneOntologyMolecularFunctioninorganic cation transmembrane transporter activity

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A SLC25A13 KCNK15 KCNK3 SLC30A3 KCNK9 RYR3 TFRC

4.25e-076276212GO:0022890
GeneOntologyMolecularFunctionmetal ion transmembrane transporter activity

SLC6A1 CACNG2 ATP13A4 SCN11A KCNK15 KCNK3 SLC30A3 KCNK9 RYR3 TFRC

1.55e-064656210GO:0046873
GeneOntologyMolecularFunctionsecondary active transmembrane transporter activity

SLC6A1 SLC25A3 SLC22A8 SLC16A5 SLC6A16 SLC25A13 SLC22A11 SLC30A3

3.58e-06296628GO:0015291
GeneOntologyMolecularFunctionchannel activity

CACNG2 SCN11A PIEZO2 KCNK15 KCNK3 MPEG1 KCNK9 ANO3 AQP9 RYR3

4.57e-065256210GO:0015267
GeneOntologyMolecularFunctionpassive transmembrane transporter activity

CACNG2 SCN11A PIEZO2 KCNK15 KCNK3 MPEG1 KCNK9 ANO3 AQP9 RYR3

4.64e-065266210GO:0022803
GeneOntologyMolecularFunctionactive transmembrane transporter activity

SLC6A1 SLC25A3 ATP13A4 SLC22A8 SLC16A5 SLC6A16 SLC25A13 SLC22A11 SLC30A3

1.55e-05477629GO:0022804
GeneOntologyMolecularFunctionpotassium ion leak channel activity

KCNK15 KCNK3 KCNK9

1.55e-0516623GO:0022841
GeneOntologyMolecularFunctionnarrow pore channel activity

KCNK15 KCNK3 KCNK9

2.67e-0519623GO:0022842
GeneOntologyMolecularFunctionleak channel activity

KCNK15 KCNK3 KCNK9

2.67e-0519623GO:0022840
GeneOntologyMolecularFunctiongated channel activity

CACNG2 PIEZO2 KCNK15 KCNK3 KCNK9 ANO3 RYR3

7.68e-05334627GO:0022836
GeneOntologyMolecularFunctionoutward rectifier potassium channel activity

KCNK15 KCNK3 KCNK9

7.91e-0527623GO:0015271
GeneOntologyMolecularFunctionmonoatomic ion channel activity

CACNG2 SCN11A PIEZO2 KCNK15 KCNK3 KCNK9 ANO3 RYR3

8.35e-05459628GO:0005216
GeneOntologyMolecularFunctionmonoatomic cation channel activity

CACNG2 SCN11A PIEZO2 KCNK15 KCNK3 KCNK9 RYR3

9.07e-05343627GO:0005261
GeneOntologyMolecularFunctioninorganic anion transmembrane transporter activity

SLC6A1 SLC25A3 SLC22A8 SLC22A11 ANO3

1.89e-04171625GO:0015103
GeneOntologyMolecularFunctionpore-forming activity

MPEG1 MMD2

4.20e-0410622GO:0140911
GeneOntologyMolecularFunctionprostaglandin transmembrane transporter activity

SLC22A8 SLC22A11

8.43e-0414622GO:0015132
GeneOntologyMolecularFunctionantiporter activity

SLC22A8 SLC25A13 SLC22A11 SLC30A3

8.93e-04138624GO:0015297
GeneOntologyMolecularFunctionicosanoid transmembrane transporter activity

SLC22A8 SLC22A11

9.70e-0415622GO:0071714
GeneOntologyMolecularFunctionsymporter activity

SLC6A1 SLC25A3 SLC16A5 SLC6A16

1.22e-03150624GO:0015293
GeneOntologyMolecularFunctionvoltage-gated monoatomic cation channel activity

CACNG2 KCNK15 KCNK3 KCNK9

1.28e-03152624GO:0022843
GeneOntologyMolecularFunctionadenylate cyclase activity

ADCY10 GUCY1B1

1.41e-0318622GO:0004016
GeneOntologyMolecularFunctionorganic anion transmembrane transporter activity

SLC6A1 SLC22A8 SLC16A5 SLC25A13 SLC22A11

2.15e-03293625GO:0008514
GeneOntologyMolecularFunctionvoltage-gated monoatomic ion channel activity

CACNG2 KCNK15 KCNK3 KCNK9

2.47e-03182624GO:0005244
GeneOntologyMolecularFunctioncyclase activity

ADCY10 GUCY1B1

2.51e-0324622GO:0009975
GeneOntologyMolecularFunctionvoltage-gated channel activity

CACNG2 KCNK15 KCNK3 KCNK9

2.57e-03184624GO:0022832
GeneOntologyMolecularFunctionphosphorus-oxygen lyase activity

ADCY10 GUCY1B1

2.72e-0325622GO:0016849
GeneOntologyMolecularFunctionvoltage-gated potassium channel activity

KCNK15 KCNK3 KCNK9

3.93e-03102623GO:0005249
GeneOntologyMolecularFunctionsolute:inorganic anion antiporter activity

SLC22A8 SLC22A11

4.43e-0332622GO:0005452
GeneOntologyMolecularFunctionexopeptidase activity

ERAP1 SCPEP1 ATG4D

4.86e-03110623GO:0008238
GeneOntologyMolecularFunctiontumor necrosis factor receptor binding

TRAP1 ERAP1

5.28e-0335622GO:0005164
GeneOntologyMolecularFunctionpotassium channel activity

KCNK15 KCNK3 KCNK9

7.39e-03128623GO:0005267
GeneOntologyBiologicalProcessmonoatomic ion transport

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A PIEZO2 SLC22A8 SLC6A16 SLC25A13 KCNK15 SLC22A11 KCNK3 CCR1 SLC30A3 KCNK9 ANO3 CLDN10 RYR3 TFRC

1.07e-0813746219GO:0006811
GeneOntologyBiologicalProcessmonoatomic cation transport

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A PIEZO2 SLC6A16 SLC25A13 KCNK15 KCNK3 CCR1 SLC30A3 KCNK9 RYR3 TFRC

1.21e-0611576215GO:0006812
GeneOntologyBiologicalProcessmonoatomic cation transmembrane transport

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A PIEZO2 SLC6A16 SLC25A13 KCNK15 KCNK3 SLC30A3 KCNK9 RYR3

3.59e-069426213GO:0098655
GeneOntologyBiologicalProcessmonoatomic ion transmembrane transport

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A PIEZO2 SLC6A16 SLC25A13 KCNK15 KCNK3 SLC30A3 KCNK9 ANO3 RYR3

4.26e-0611156214GO:0034220
GeneOntologyBiologicalProcessinorganic ion transmembrane transport

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A SLC6A16 SLC25A13 KCNK15 KCNK3 SLC30A3 KCNK9 ANO3 RYR3

8.24e-0610176213GO:0098660
GeneOntologyBiologicalProcessinorganic cation transmembrane transport

SLC6A1 CACNG2 SLC25A3 ATP13A4 SCN11A SLC6A16 SLC25A13 KCNK15 KCNK3 SLC30A3 KCNK9 RYR3

1.62e-059226212GO:0098662
GeneOntologyBiologicalProcessstabilization of membrane potential

KCNK15 KCNK3 KCNK9

1.71e-0517623GO:0030322
GeneOntologyBiologicalProcessmetal ion transport

SLC6A1 CACNG2 ATP13A4 SCN11A SLC6A16 KCNK15 KCNK3 CCR1 SLC30A3 KCNK9 RYR3 TFRC

3.61e-0510006212GO:0030001
GeneOntologyBiologicalProcessdetection of temperature stimulus

SCN11A ANO3 EPHB1

1.32e-0433623GO:0016048
GeneOntologyBiologicalProcessinorganic anion transport

SLC6A1 SLC25A3 SLC22A8 SLC22A11 ANO3

2.07e-04180625GO:0015698
GeneOntologyBiologicalProcessresponse to metal ion

SLC6A1 CACNG2 SLC25A13 KCNK3 SLC30A3 RYR3 TFRC

2.41e-04415627GO:0010038
GeneOntologyBiologicalProcessantigen processing and presentation of peptide antigen via MHC class I

ERAP1 MFSD6 MPEG1

2.54e-0441623GO:0002474
GeneOntologyCellularComponentbasal part of cell

ADCY10 SLC22A8 SLC16A5 SLC22A11 NAIP AQP9 TFRC

1.25e-04378627GO:0045178
Domain2pore_dom_K_chnl_TASK

KCNK15 KCNK3 KCNK9

2.88e-069623IPR003092
DomainCXorf40

EOLA2 EOLA1

1.08e-052622IPR033615
Domain2pore_dom_K_chnl

KCNK15 KCNK3 KCNK9

1.54e-0515623IPR003280
DomainASCH_domain

EOLA2 EOLA1

3.25e-053622IPR007374
DomainASCH

EOLA2 EOLA1

3.25e-053622SM01022
DomainK_chnl_dom

KCNK15 KCNK3 KCNK9

4.44e-0521623IPR013099
DomainIon_trans_2

KCNK15 KCNK3 KCNK9

4.44e-0521623PF07885
DomainMFS_1

SLC22A8 SLC16A5 MFSD6 SLC22A11

1.24e-0477624PF07690
DomainMFS

SLC22A8 SLC16A5 MFSD6 SLC22A11

1.24e-0477624IPR011701
DomainMFS

SLC22A8 SLC16A5 MFSD6 SLC22A11

4.56e-04108624PS50850
DomainMFS_dom

SLC22A8 SLC16A5 MFSD6 SLC22A11

1.02e-03134624IPR020846
DomainNA_NEUROTRAN_SYMP_2

SLC6A1 SLC6A16

1.60e-0318622PS00754
DomainNucleotide_cyclase

ADCY10 GUCY1B1

1.60e-0318622IPR029787
Domain-

ADCY10 GUCY1B1

1.60e-03186223.30.70.1230
DomainPUA-like_domain

EOLA2 EOLA1

1.79e-0319622IPR015947
DomainGUANYLATE_CYCLASE_1

ADCY10 GUCY1B1

1.79e-0319622PS00452
DomainSNF

SLC6A1 SLC6A16

1.79e-0319622PF00209
DomainGuanylate_cyc

ADCY10 GUCY1B1

1.79e-0319622PF00211
DomainNA_NEUROTRAN_SYMP_1

SLC6A1 SLC6A16

1.79e-0319622PS00610
DomainGUANYLATE_CYCLASE_2

ADCY10 GUCY1B1

1.79e-0319622PS50125
DomainNA_NEUROTRAN_SYMP_3

SLC6A1 SLC6A16

1.79e-0319622PS50267
DomainA/G_cyclase

ADCY10 GUCY1B1

1.79e-0319622IPR001054
DomainCYCc

ADCY10 GUCY1B1

1.79e-0319622SM00044
DomainNa/ntran_symport

SLC6A1 SLC6A16

1.79e-0319622IPR000175
DomainClaudin

CACNG2 CLDN10

3.88e-0328622IPR006187
DomainKringle-like

KREMEN1 SLC22A8

5.04e-0332622IPR013806
DomainRibosomal_S5_D2-typ_fold

TRAP1 EFTUD2

5.68e-0334622IPR020568
DomainMFS_sugar_transport-like

SLC22A8 SLC22A11

6.35e-0336622IPR005828
DomainSugar_tr

SLC22A8 SLC22A11

6.35e-0336622PF00083
DomainPMP22_Claudin

CACNG2 CLDN10

7.80e-0340622PF00822
DomainPMP22/EMP/MP20/Claudin

CACNG2 CLDN10

9.79e-0345622IPR004031
PathwayREACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL

KCNK15 KCNK3 KCNK9

3.91e-0519503M27452
PathwayREACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL

KCNK15 KCNK3 KCNK9

3.91e-0519503MM15194
PathwayREACTOME_TRANSPORT_OF_SMALL_MOLECULES

SLC6A1 ATP13A4 SLC22A8 SLC22A11 CUBN SLC30A3 ANO3 AQP9 SOAT1 RYR3 TFRC

4.20e-057365011M27287
PathwayREACTOME_MUSCLE_CONTRACTION

SCN11A GUCY1B1 KCNK15 KCNK3 KCNK9 RYR3

7.76e-05203506M5485
PathwayREACTOME_CARDIAC_CONDUCTION

SCN11A KCNK15 KCNK3 KCNK9 RYR3

9.38e-05130505M27454
PathwayREACTOME_ORGANIC_ANION_TRANSPORT

SLC22A8 SLC22A11

1.22e-045502M27469
PathwayREACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS

SLC6A1 SLC22A8 SLC22A11 SLC30A3

2.19e-0484504M27334
PathwayREACTOME_MUSCLE_CONTRACTION

GUCY1B1 KCNK15 KCNK3 KCNK9 RYR3

2.86e-04165505MM15026
PathwayREACTOME_CARDIAC_CONDUCTION

KCNK15 KCNK3 KCNK9 RYR3

4.78e-04103504MM15196
PathwayREACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS

KCNK3 KCNK9

6.64e-0411502MM14547
PathwayREACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS

KCNK3 KCNK9

7.95e-0412502M1071
Pubmed

Potassium channel TASK-5 forms functional heterodimers with TASK-1 and TASK-3 to break its silence.

KCNK15 KCNK3 KCNK9

5.94e-09364339215006
Pubmed

Interaction with 14-3-3 proteins promotes functional expression of the potassium channels TASK-1 and TASK-3.

KCNK15 KCNK3 KCNK9

7.07e-071064312433946
Pubmed

International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels.

KCNK15 KCNK3 KCNK9

2.13e-061464316382106
Pubmed

Acid sensitive background potassium channels K2P3.1 and K2P9.1 undergo rapid dynamin-dependent endocytosis.

KCNK3 KCNK9

3.33e-06264223807092
Pubmed

Lack of p11 expression facilitates acidity-sensing function of TASK1 channels in mouse adrenal medullary cells.

KCNK3 KCNK9

3.33e-06264230001168
Pubmed

TASK-1 and TASK-3 channels modulate pressure overload-induced cardiac remodeling and dysfunction.

KCNK3 KCNK9

3.33e-06264231977249
Pubmed

Oxygen and mitochondrial inhibitors modulate both monomeric and heteromeric TASK-1 and TASK-3 channels in mouse carotid body type-1 cells.

KCNK3 KCNK9

3.33e-06264224042502
Pubmed

Pancreatic β-cell-specific ablation of TASK-1 channels augments glucose-stimulated calcium entry and insulin secretion, improving glucose tolerance.

KCNK3 KCNK9

3.33e-06264224932805
Pubmed

Contractile and electrophysiological properties of pulmonary artery smooth muscle are not altered in TASK-1 knockout mice.

KCNK3 KCNK9

3.33e-06264221486782
Pubmed

An unexpected role for TASK-3 potassium channels in network oscillations with implications for sleep mechanisms and anesthetic action.

KCNK3 KCNK9

3.33e-06264219805135
Pubmed

Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action.

KCNK3 KCNK9

3.33e-06264211886861
Pubmed

A role for TASK-1 (KCNK3) channels in the chemosensory control of breathing.

KCNK3 KCNK9

3.33e-06264218753386
Pubmed

Abnormal respiration under hyperoxia in TASK-1/3 potassium channel double knockout mice.

KCNK3 KCNK9

3.33e-06264228673876
Pubmed

Differential phospholipase C-dependent modulation of TASK and TREK two-pore domain K+ channels in rat thalamocortical relay neurons.

KCNK3 KCNK9

3.33e-06264225556792
Pubmed

TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functions.

KCNK3 KCNK9

3.33e-06264218375952
Pubmed

Variations in the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone production: an exploratory study.

KCNK3 KCNK9

3.33e-06264222893713
Pubmed

Changes in TWIK-related acid sensitive K+-1 and -3 channel expressions from neurons to glia in the hippocampus of temporal lobe epilepsy patients and experimental animal model.

KCNK3 KCNK9

3.33e-06264221710317
Pubmed

TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation.

KCNK3 KCNK9

3.33e-06264220049674
Pubmed

Expression of p11 and heteromeric TASK channels in mouse adrenal cortical cells and H295R cells.

KCNK3 KCNK9

3.33e-06264235526370
Pubmed

Altered neuronal expression of TASK1 and TASK3 potassium channels in rodent and human autoimmune CNS inflammation.

KCNK3 KCNK9

3.33e-06264218824070
Pubmed

KT3.2 and KT3.3, two novel human two-pore K(+) channels closely related to TASK-1.

KCNK15 KCNK9

3.33e-06264211431495
Pubmed

Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channels.

KCNK3 KCNK9

3.33e-06264231423744
Pubmed

Deletion of TASK1 and TASK3 channels disrupts intrinsic excitability but does not abolish glucose or pH responses of orexin/hypocretin neurons.

KCNK3 KCNK9

3.33e-06264219508695
Pubmed

TASK-5, a novel member of the tandem pore K+ channel family.

KCNK15 KCNK3

3.33e-06264211680614
Pubmed

Expression of the kcnk3 potassium channel gene lessens the injury from cerebral ischemia, most likely by a general influence on blood pressure.

KCNK3 KCNK9

3.33e-06264220167264
Pubmed

TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity.

KCNK3 KCNK9

3.33e-06264218094244
Pubmed

Expression pattern in brain of TASK-1, TASK-3, and a tandem pore domain K(+) channel subunit, TASK-5, associated with the central auditory nervous system.

KCNK15 KCNK9

3.33e-06264211749039
Pubmed

TASK channels contribute to neuroprotective action of inhalational anesthetics.

KCNK3 KCNK9

3.33e-06264228276488
Pubmed

TASK channel deletion in mice causes primary hyperaldosteronism.

KCNK3 KCNK9

3.33e-06264218250325
Pubmed

TASK-like conductances are present within hippocampal CA1 stratum oriens interneuron subpopulations.

KCNK3 KCNK9

3.33e-06264216837582
Pubmed

Functional TASK-3-Like Channels in Mitochondria of Aldosterone-Producing Zona Glomerulosa Cells.

KCNK3 KCNK9

3.33e-06264228630209
Pubmed

Rapid developmental maturation of neocortical FS cell intrinsic excitability.

KCNK3 KCNK9

3.33e-06264220705896
Pubmed

Probing the regulation of TASK potassium channels by PI4,5P₂ with switchable phosphoinositide phosphatases.

KCNK3 KCNK9

3.33e-06264221540350
Pubmed

Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9.

KCNK3 KCNK9

3.33e-06264218678320
Pubmed

Biophysical properties of human medulloblastoma cells.

KCNK3 KCNK9

3.33e-06264220931182
Pubmed

TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.

KCNK3 KCNK9

3.33e-06264225655935
Pubmed

TWIK-related acid-sensitive potassium channels TASK-1 and TASK-3 may participate in the process of the coexistence of asthma and OSA.

KCNK3 KCNK9

3.33e-06264237428352
Pubmed

TASK channels are not required to mount an aldosterone secretory response to metabolic acidosis in mice.

KCNK3 KCNK9

3.33e-06264221111026
Pubmed

Neuropathy-causing mutations in HSPB1 impair autophagy by disturbing the formation of SQSTM1/p62 bodies.

SLC25A3 SLC25A13 SEC16A TFRC

7.32e-066764430669930
Pubmed

Diacylglycerol mediates regulation of TASK potassium channels by Gq-coupled receptors.

KCNK3 KCNK9

9.99e-06364225420509
Pubmed

Differential distribution of TASK-1, TASK-2 and TASK-3 immunoreactivities in the rat and human cerebellum.

KCNK3 KCNK9

9.99e-06364215197476
Pubmed

Protein kinase A is central for forward transport of two-pore domain potassium channels K2P3.1 and K2P9.1.

KCNK3 KCNK9

9.99e-06364221357689
Pubmed

Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA.

KCNK3 KCNK9

9.99e-06364223164059
Pubmed

KCNK5 channels mostly expressed in cochlear outer sulcus cells are indispensable for hearing.

KCNK3 KCNK9

9.99e-06364226549439
Pubmed

Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.

SLC25A3 TRAP1 SLC25A13 PABPC4 SEC16A KCNK3 TFRC EFTUD2

1.02e-0557364828330616
Pubmed

BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.

SLC25A3 SLC25A13 SEC16A TFRC EFTUD2

1.05e-0515664532850835
Pubmed

Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules.

SLC22A8 SLC22A11

2.00e-05464215037815
Pubmed

Human organic anion transporters mediate the transport of tetracycline.

SLC22A8 SLC22A11

2.00e-05464211855680
Pubmed

130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus.

EOLA2 EOLA1

2.00e-0546428717057
Pubmed

Expression of Proton-Sensitive GPR31, GPR151, TASK1 and TASK3 in Common Skin Tumors.

KCNK3 KCNK9

2.00e-05464235011589
Pubmed

Sp1-regulated expression of p11 contributes to motor neuron degeneration by membrane insertion of TASK1.

KCNK3 KCNK9

2.00e-05464231439839
Pubmed

Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα.

SLC25A3 TRAP1 SLC25A13 SEC16A EFTUD2

2.21e-0518264532239614
Pubmed

MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.

TRAP1 ERAP1 SLC25A13 TFRC EFTUD2

2.21e-0518264530711629
Pubmed

K(+) efflux through two-pore domain K(+) channels is required for mouse embryonic development.

KCNK3 KCNK9

3.32e-05564222419831
Pubmed

Volume regulation of murine T lymphocytes relies on voltage-dependent and two-pore domain potassium channels.

KCNK3 KCNK9

3.32e-05564221575593
Pubmed

Glucose inhibition persists in hypothalamic neurons lacking tandem-pore K+ channels.

KCNK3 KCNK9

3.32e-05564219244527
Pubmed

Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 With Behçet's disease in Iranians.

ERAP1 CCR1

3.32e-05564226097239
Pubmed

Adrenal Tissue-Specific Deletion of TASK Channels Causes Aldosterone-Driven Angiotensin II-Independent Hypertension.

KCNK3 KCNK9

3.32e-05564230580687
Pubmed

Enhanced tonic GABAA inhibition in typical absence epilepsy.

SLC6A1 CACNG2

3.32e-05564219966779
Pubmed

Motoneuronal TASK channels contribute to immobilizing effects of inhalational general anesthetics.

KCNK3 KCNK9

4.98e-05664220519544
Pubmed

Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.

SLC22A8 SLC22A11

4.98e-05664211907186
Pubmed

Potential use of potassium efflux-deficient yeast for studying trafficking signals and potassium channel functions.

KCNK3 KCNK9

4.98e-05664223772394
Pubmed

MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.

CCR1 IL1R1

4.98e-05664219079579
Pubmed

Stasimon/Tmem41b localizes to mitochondria-associated ER membranes and is essential for mouse embryonic development.

SLC25A3 TRAP1 SOAT1 TFRC

5.78e-0511364430352685
Pubmed

Molecular and phenotypic variation in patients with severe Hunter syndrome.

EOLA2 EOLA1

6.96e-0576429147653
Pubmed

Kv1.1 channels act as mechanical brake in the senses of touch and pain.

KCNK3 KCNK9

6.96e-05764223473320
Pubmed

Differential Targeting of SLC30A10/ZnT10 Heterodimers to Endolysosomal Compartments Modulates EGF-Induced MEK/ERK1/2 Activity.

SLC30A3 TFRC

6.96e-05764226728129
Pubmed

A role for Piezo2 in EPAC1-dependent mechanical allodynia.

SCN11A PIEZO2

6.96e-05764223575686
Pubmed

Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.

SLC6A1 CACNG2 GRM3

7.98e-054564325979088
Pubmed

A Non-canonical Voltage-Sensing Mechanism Controls Gating in K2P K(+) Channels.

KCNK3 KCNK9

9.27e-05864226919430
Pubmed

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1.

ERAP1 CCR1

9.27e-05864223291587
Pubmed

Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation.

SLC25A3 PRKD3 TRAP1 TFRC EFTUD2

1.15e-0425864521081666
Pubmed

Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.

SLC22A8 TFRC

1.81e-041164218619525
Pubmed

SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.

SLC25A3 TRAP1 SLC25A13 PABPC4 TFRC EFTUD2

2.10e-0446364634901782
Pubmed

Roles of BLOC-1 and adaptor protein-3 complexes in cargo sorting to synaptic vesicles.

SLC30A3 TFRC

2.17e-041264219144828
Pubmed

Potassium leak channels and the KCNK family of two-P-domain subunits.

KCNK3 KCNK9

2.17e-041264211256078
Pubmed

Mouse models of adrenocortical tumors.

KCNK3 KCNK9

2.17e-041264226678830
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

SLC25A3 SLC25A13 PURB PABPC4 SEC16A SLC30A3 EFTUD2

2.46e-0467864730209976
Pubmed

Retrograde regulation of mossy fiber axon targeting and terminal maturation via postsynaptic Lnx1.

SLC30A3 EPHB1

2.57e-041364230185604
Pubmed

Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.

SLC25A3 SLC25A13 TFRC

3.37e-047364323464991
Pubmed

Common body mass index-associated variants confer risk of extreme obesity.

EML6 ANO3

3.45e-041564219553259
Pubmed

Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A.

TRAP1 SLC25A13 PABPC4

4.74e-048264330274258
Pubmed

Protein interaction screening for the ankyrin repeats and suppressor of cytokine signaling (SOCS) box (ASB) family identify Asb11 as a novel endoplasmic reticulum resident ubiquitin ligase.

SLC25A3 SLC25A13 TFRC EFTUD2

4.96e-0419864424337577
Pubmed

A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.

SLC25A3 TRAP1 SLC25A13 PABPC4 SEC16A SOAT1 TFRC

5.95e-0478664729128334
Pubmed

The European renal genome project: an integrated approach towards understanding the genetics of kidney development and disease.

SLC6A1 SLC25A3 AQP9 CLDN10

6.40e-0421264419521566
Pubmed

TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.

TRAP1 SLC25A13 PABPC4

6.43e-049164334445801
Pubmed

Rescue of neuropsychiatric phenotypes in a mouse model of 16p11.2 duplication syndrome by genetic correction of an epilepsy network hub.

SLC6A1 SLC25A3 GRM3 SLC30A3

6.75e-0421564436808153
Pubmed

GREB1: An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer.

SLC25A3 SLC25A13 PURB PABPC4

7.73e-0422364433731348
Pubmed

IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation.

NAIP IL1R1

8.23e-042364229576451
Pubmed

Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs.

SLC25A3 SLC25A13 PABPC4

8.71e-0410164319167051
Pubmed

The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.

TFRC EFTUD2

8.96e-042464224798327
Pubmed

A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.

PABPC4 EFTUD2

8.96e-042464233705438
Pubmed

Developmental abnormalities in cortical GABAergic system in mice lacking mGlu3 metabotropic glutamate receptors.

SLC6A1 GRM3

9.73e-042564231665922
Pubmed

Network organization of the huntingtin proteomic interactome in mammalian brain.

SLC6A1 SLC25A3 TRAP1 ERAP1 SLC25A13 NAIP

9.86e-0462164622794259
Pubmed

Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells.

CCR1 IL1R1

1.05e-032664219006696
Pubmed

CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling.

SLC25A13 SEC16A DCAF11

1.06e-0310864330166453
Pubmed

Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.

SLC25A3 PABPC4 SEC16A EFTUD2

1.08e-0324464428902428
Pubmed

Characterization of the zinc-induced Shank3 interactome of mouse synaptosome.

SLC6A1 SLC25A3 PURB

1.09e-0310964329111324
Pubmed

Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.

SLC25A3 SLC25A13 EFTUD2

1.14e-0311164332683582
Pubmed

∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.

SLC25A3 ERAP1 SLC25A13 PURB PABPC4 SEC16A

1.22e-0364764626618866
GeneFamilyPotassium two pore domain channel subfamily K

KCNK15 KCNK3 KCNK9

7.81e-0615483277
GeneFamilySolute carriers

SLC6A1 SLC25A3 SLC22A8 SLC16A5 SLC6A16 SLC25A13 SLC22A11 SLC30A3

8.49e-06395488752
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC6A1 ATP13A4 GRM3 CLDN10 MMD2 RYR3 C16orf89

1.55e-0820064707d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC6A1 ATP13A4 GRM3 CLDN10 RYR3 C16orf89

4.33e-072006467a8160e6477708f22e48c609bf8f43f3715dcb03
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC6A1 ATP13A4 GRM3 CLDN10 RYR3 C16orf89

4.33e-07200646d0812817ef99608994193787a62d39adeb2070ca
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SLC6A1 ATP13A4 GRM3 CLDN10 RYR3 C16orf89

4.33e-07200646cd54ddf1919c98e84b7e4aba85b374fc8b407206
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC6A1 ATP13A4 MMD2 CLDN10 SOAT1

5.47e-06176645ac3dc44755280e36c0947b6de3cd639dc17de8b6
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC6A1 ATP13A4 MMD2 AQP9 CLDN10

6.79e-06184645f6148e9591e8845cc62668e49fd52755257cdc7e
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC6A1 ATP13A4 MMD2 GRM3 CLDN10

8.14e-06191645fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5
ToppCellfacs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC6A1 ATP13A4 MMD2 CLDN10 SOAT1

8.35e-06192645261211a86e6f63b09c2ddce1d2d9257d311f1770
ToppCellfacs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC6A1 MMD2 GRM3 CLDN10 EPHB1

9.23e-06196645256fe9bc0815f66a9afe11ba3507ef1372b52fd3
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC6A1 PIEZO2 GUCY1B1 KCNK3 ANO3

9.46e-06197645bc6c530330907a5ec823cc243c8e9c9e340cfb9c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MPEG1 CCR1 SCPEP1 IL1R1 AQP9

9.46e-06197645ad4147435ac0fdf6274fea6d535f4e00d990e535
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC6A1 PIEZO2 GUCY1B1 KCNK3 ANO3

9.46e-0619764577fe092aae8f05fe137680506892d2f61071d6ea
ToppCellCOVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.46e-06197645344801997b89bd81d8d5c3c872934de523233a8d
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ATP13A4 GRM3 CLDN10 RYR3 C16orf89

9.46e-061976455bcf963f21d23edafef1e90dc1de24cd3b0fccce
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ATP13A4 GRM3 CLDN10 RYR3 C16orf89

9.46e-06197645bd7e18a0fed085cfb8ed0e478d1f172a173febbe
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ATP13A4 GRM3 CLDN10 RYR3 C16orf89

9.46e-061976457e06aee2add54eeff4a9927d9b04b5797160113b
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645cf0fda1a24449cfd8ed56ffc7841d8accb187949
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645d347462ba6cb1c5a59c86dffbbe914cbc1e9cf16
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645c5a22846bccff948f90bc1d5fe309907dcd08348
ToppCellCOVID-19_Mild-Myeloid-Classical_Monocyte|COVID-19_Mild / Disease group, lineage and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645e78d027a095473af555762a4d542a73f5bb2e166
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-061986457e1f08dae11a7cc7949a5622d82c7e6660d06dea
ToppCellILEUM-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

NAIP MPEG1 CCR1 SCPEP1 TFRC

9.69e-0619864530bf78d4d657cf5140549d3dbf43d4f00482e300
ToppCellPBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645a8338da2477ccf8e3d924de8dbe1056b98111532
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645525adc91fd8f2ad957b1879a5bf3950baa7d5ef8
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645c49c71b34151d82b8795763bcb633c301c35f659
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-0619864570e62d815b2a0aa5327ff94d6f4d503176e007b9
ToppCellCOVID-19_Severe-Myeloid-Classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645dfe92577c7d1e63315c7564d5d99362c6e7d4d46
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-061986450128d00e6c3f99a026329dd169c0ea5e0e24c59c
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-061986454780f0276546962a2fc9f1041cfe49d2919d72b2
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-0619864551c220507bb05aa6338fec494b8ecf4902437708
ToppCellCOVID-19_Severe-Classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645b88c4c0ed1abf0a28dbe05b04b9bee1073855ba8
ToppCellPBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-06198645603846129560d5d6e6df27d6168f67f592e5e6e2
ToppCellCOVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.69e-0619864530ada3de865b6fb2b14196a1cbfd4740c6a57ce3
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.93e-061996459314eb9a89407738626a0384884454b5f9031ee7
ToppCellCOVID-19_Severe-Myeloid|COVID-19_Severe / Disease group, lineage and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.93e-06199645babbf3220cc811a1794032e06c6cec4dfc7bff2f
ToppCellParenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CCR1 SCPEP1 AQP9 SOAT1 TFRC

9.93e-06199645f987f48970aec46156b80656e49b9f3604f3758c
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NAIP MPEG1 CCR1 SCPEP1 AQP9

9.93e-06199645dbf0bf09896c46155ae6fbd6307f097799e7e34e
ToppCellCOVID-19-COVID-19_Mild-Myeloid-CD14+_Monocyte|COVID-19_Mild / Disease, condition lineage and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

1.02e-05200645f76d3647f8ab5f7be018b0697c911597198e03f5
ToppCellsevere-Classical_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

1.02e-05200645ce03be0ccfc22eb923302a2ad73b39752e888270
ToppCellCOVID-19-COVID-19_Severe-Myeloid-CD14+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

1.02e-052006456abee30708572519045e9456dac2017b5308817a
ToppCellCOVID-19-COVID-19_Severe-Myeloid|COVID-19_Severe / Disease, condition lineage and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

1.02e-052006451315bc0582b19c2fed91c740a1a7e9285c700df1
ToppCellmild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

NAIP MPEG1 CCR1 SCPEP1 AQP9

1.02e-05200645c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ADCY10 SLC25A13 AQP9 EPHB1

2.06e-05112644ef8fdb35a4d295f7e4a0a4029e5965c1f17e413a
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

KREMEN1 NAIP SLC30A3 TFRC

2.53e-051186447e6cb77fa9154f2da985c455bb6a24d6029cc8d6
ToppCellPND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass

SLC22A8 ADAMTS3 GUCY1B1 KCNK3

4.28e-0513564435928195cf34f055b353562c96f451aef2344d64
ToppCellLPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KCNK3 CUBN GRM3 EPHB1

4.80e-051396442fb51abb3ce88c21726c026d6365b2582e2e79f6
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC16A5 CCR1 AQP9 EPHB1

5.07e-051416442d2c468783730d81e3cacb0336027ba0ce1e5f4f
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ANO3 CLDN10 RYR3 EPHB1

6.62e-05151644f50c5ae9dae507df750df25e151b58685fec70ce
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9

SLC6A1 CACNG2 KCNK3 MMD2

8.49e-051616445f6b2d7f80a8ee16651e304481d2da3fae313824
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 KCNK15 KCNK3 ANO3

8.91e-05163644bbc078761c5043af13d9a6fcf3145a3e300bae5e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 KCNK15 KCNK3 ANO3

8.91e-051636448e32b6431e1862572663aa6ddc4ea299c6acc8a6
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 KCNK3 GRM3 ANO3

9.12e-05164644f6a961fa2002da7d9679f32af99e1314c0593ef9
ToppCelldroplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DPAGT1 GTF2A1L CUBN CATSPERG

9.34e-0516564421a82a975f550080b6674750b06212205cd16742
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC6A1 KCNK15 CLDN10 C16orf89

1.02e-04169644db73dae011ff3749b3706e50ab46d03b775dd6bb
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC6A1 KCNK15 CLDN10 C16orf89

1.02e-0416964497b7047b87ce0052d8580565c9b44fd2aa6f0d5c
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SLC6A1 KCNK15 CLDN10 C16orf89

1.02e-041696441a684471dbda42e1470e5a889648666e14f25982
ToppCellmetastatic_Lymph_Node-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass

TRBV24-1 EOLA1 SLC30A3 CD200

1.02e-041696443d48acea7482bbe5bb9da4c3af5f9b0c9800122f
ToppCellCOVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type

ADAMTS3 GUCY1B1 IL1R1 CD200

1.10e-0417264436a96714a0eb6ac438648135336c9791881ddadb
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS3 GRM3 SLC30A3 ANO3

1.12e-041736449a2d42f8d9cb834856522661d524abb91c4637c5
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GRM3 SLC30A3 ANO3 RYR3

1.15e-04174644ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCellCF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class

SLC25A13 IL1R1 AQP9 EPHB1

1.17e-041756448020c3a34f77e68e8149f87481fb1dddd2ac675e
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PIEZO2 SLC16A5 CLDN10 CD200

1.17e-041756440992de1c7bffcb6890584357a7a0a8955927da6c
ToppCelldroplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APH1B ATP13A4 MPEG1 SOAT1

1.20e-041766448e89471f838ea81235256cc2470f1c12c9b75f8a
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NAIP SCPEP1 AQP9 TFRC

1.22e-04177644382f0d6bbff01e84b0c7840e74ac865864e6da89
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ATP13A4 EML6 AQP9 CD200

1.22e-04177644da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCellCOVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC22A8 SLC22A11 CUBN CLDN10

1.25e-0417864423a12d3d971b857d5be8e907334d1f6b49eeeb32
ToppCellMid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SLC22A8 ADAMTS3 SCPEP1 ANO3

1.25e-04178644ad187db4c40b9078d54dd915c143e0172b2f47b8
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SLC22A8 SLC22A11 CUBN CLDN10

1.33e-041816449542c19edc9bd2cba68c01c2a8407705398e3011
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SLC22A8 SLC22A11 CUBN CLDN10

1.33e-041816448f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCellCOVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC22A8 SLC22A11 CUBN CLDN10

1.33e-041816446980ea624151da32b7f537f263e40fcb87a02e81
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC22A8 SLC22A11 CUBN CLDN10

1.36e-04182644e1e58176f533092b6b974ca1ce8b02192a6e193d
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CCR1 AQP9 SOAT1 TFRC

1.36e-041826444234d0cc57b5266a5e03133c75c7918abe48465e
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SCN11A GUCY1B1 KCNK3 GRM3

1.36e-04182644fc4a5bf784705efe7965ce43ac23c2a8e602e90a
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS3 SLC30A3 ANO3 CFAP46

1.36e-0418264414a117c5e50db31ee1b2cf4df4d133451fd6d55f
ToppCell5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAIP MPEG1 CCR1 AQP9

1.36e-041826441fb9bdf2e9f0a9c230f109b471672f9c31e27c82
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SLC22A8 SLC22A11 CUBN CLDN10

1.36e-0418264457bb5a2da976464ba7c4460106bd9f692008ebd9
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC22A8 SLC22A11 CUBN CLDN10

1.39e-0418364484b64cf728629c3af9a8d2ed15b93adf562c54b8
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNG2 ADAMTS3 ANO3 RYR3

1.39e-04183644bf7f1cb55ed55981b8b355d5774055c96e658ff2
ToppCell3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DCAF11 PTGDR IL1R1 ATG4D

1.39e-04183644f079179f2984def91ddf0b33d7949d5ecdbd380d
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CACNG2 ADAMTS3 ANO3 RYR3

1.39e-041836449533db4db2c6ae78d7ca1682cf4efed12183396f
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PIEZO2 SLC16A5 CLDN10 CD200

1.39e-041836447eaa6ef7c6cf848fd6489f97677f4406318da22f
ToppCellCF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class

SLC25A13 IL1R1 AQP9 EPHB1

1.39e-04183644da43827952e6fdee2ce94648c316182f272b321c
ToppCell3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DCAF11 PTGDR IL1R1 ATG4D

1.39e-0418364449e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP13A4 PIEZO2 ANO3 RYR3

1.42e-041846442cbed6462fea2622871bb7e49b0df3d984239281
ToppCellNS-moderate-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

NAIP CCR1 AQP9 EPHB1

1.42e-041846444c7d05f1a4556b13cedbaaf88d67ac32d09b109b
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP13A4 PIEZO2 ANO3 RYR3

1.42e-04184644ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ATP13A4 PIEZO2 ANO3 RYR3

1.42e-041846442b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellCOVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type

SLC22A8 SLC22A11 CUBN CLDN10

1.42e-04184644dc71f22583fc54b89b242cbb602f4bbe86f576ec
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC6A1 PIEZO2 GUCY1B1 ANO3

1.45e-041856447092436b4db90289516ed130ade596e3021cffaf
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC6A1 PIEZO2 GUCY1B1 ANO3

1.45e-04185644a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLC25A13 CCR1 IL1R1 AQP9

1.45e-0418564442690b95e2e7d56c822211bb1150acb787cfe2e8
ToppCellCOVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC22A8 SLC22A11 CUBN CLDN10

1.45e-041856441bbc2ba8a20f72f61981b1301cdd6018cdd9150d
ToppCell3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MPEG1 CCR1 AQP9 TFRC

1.48e-04186644bec4767eaca28e41da373274704895eba75063e2
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC22A8 SLC22A11 CUBN CLDN10

1.48e-041866448287146f0ba415ea04475588117d4668ae00f75c
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC6A1 MMD2 CLDN10 SOAT1

1.48e-04186644ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SLC22A8 SLC22A11 CUBN CLDN10

1.48e-041866445784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCelldroplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GUCY1B1 KCNK3 PTGDR MAP3K6

1.51e-04187644ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SLC22A8 SLC22A11 CUBN CLDN10

1.51e-0418764471eb26ebf60cb0848e5bf1cd01edccda621aecd8
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PIEZO2 KCNK3 GRM3 ANO3

1.51e-0418764415d6e158562d7d85af3ceaf955439b379c8fce81
ToppCellCOVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type

SLC22A8 SLC22A11 CUBN CLDN10

1.51e-04187644738ec2611b4be6a08eedad16b57fba84e1f11fef
Drugtorasemide

SLC22A8 SLC16A5 SLC22A11 KCNK3

1.92e-0633624CID000041781
DrugNSC759587

SLC6A1 CACNG2 PRKD3 KCNK15 NAIP GRM3 IL1R1 SLC30A3 MAP3K6

3.06e-06444629CID000003816
DrugCarbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A

SCN11A GUCY1B1 ERAP1 SLC30A3 CD200 EPHB1

1.46e-051946265610_UP
Drugsanshool

KCNK3 KCNK9

4.36e-054622ctd:C100574
Drugglutaric acid

SLC22A8 SLC22A11

4.36e-054622ctd:C035736
Drugtetraethylammonium

PRKD3 SLC22A8 GUCY1B1 SLC22A11 KCNK3 KCNK9

4.41e-05236626CID000005413
Drug5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid

DPAGT1 SLC25A13 GRM3 EFTUD2

4.71e-0573624CID011963505
Drugverapamil

CACNG2 PRKD3 ADCY10 SLC22A8 KCNK15 MYO3B KCNK9 RYR3

5.30e-05490628CID000002520
Drugoriens

SLC6A1 KCNK3 GRM3 KCNK9 AQP9

6.29e-05154625CID000161645
DrugAC1L38YU

SLC22A8 MFSD6 KCNK3 KCNK9

6.43e-0579624CID000085196
Drug6-carboxyfluorescein

SLC22A8 SLC22A11

7.26e-055622ctd:C024098
DrugAC1NT073

KCNK3 KCNK9

7.26e-055622CID005321101
Diseaselobe size

MYO3B EPHB1

3.76e-0414612EFO_0007666
Diseaseurate measurement

APH1B TRAP1 MYO3B SLC22A11 CUBN SLC30A3 KCNK9 CLDN10

4.93e-04895618EFO_0004531
Diseasemean arterial pressure

PRKD3 GUCY1B1 ERAP1 PABPC4 EML6 KCNK3

5.74e-04499616EFO_0006340
DiseaseBehcet Syndrome

ERAP1 CCR1

1.13e-0324612C0004943
Diseaseresponse to angiotensin receptor blocker

EML6 KCNK3

1.76e-0330612EFO_0010735

Protein segments in the cluster

PeptideGeneStartEntry
MAAAGFYFTGVKSGI

NAIP

81

Q13075
FGIYYDGLMSFAGGK

AQP9

121

O43315
MTAAVFFGCAFIAFG

APH1B

1

Q8WW43
KGGYLMLSFIDFCPF

CATSPERG

626

Q6ZRH7
MKFGCLSFRQPYAGF

EOLA1

1

Q8TE69
MKFGCLSFRQPYAGF

EOLA2

1

Q96DE9
MFCGMGGFSDFYKLR

C16orf89

256

Q6UX73
FQKLDYFVGMCGDGA

ATP13A4

836

Q4VNC1
GVGLSYCMTFFFIAK

GRM3

621

Q14832
LGSCSGFFFYGMESF

CFAP46

2471

Q8IYW2
FMFDKGCSFLCVFGF

ADCY10

336

Q96PN6
ATFYSLKGEVCFNMG

ADCY10

1131

Q96PN6
FFGSIFALFGMKCTK

CLDN10

91

P78369
KGFFNCDGFLALMGV

CALML6

86

Q8TD86
FFDLSELGMGKSGYC

ANO3

871

Q9BYT9
LAFCALPFMGFGKFV

PTGDR

161

Q13258
GKMTNFSFGGVYQEC

MPEG1

371

Q2M385
PGTDAGKAFCMFYAV

KCNK9

101

Q9NPC2
FMGGLCIAASEFYKT

CACNG2

116

Q9Y698
VAGYGKFSGKMCFQT

EPHB1

511

P54762
MLEDGRSKGFGFVCF

PABPC4

326

Q13310
GCFAQMYFILLFGGT

OR10A3

96

P58181
LFGGTECFLLGAMAY

OR10A3

106

P58181
GVFYCLGMVFFKSDG

MMD2

216

Q8IY49
TFLGYSMQGLCKFGF

SLC25A3

126

Q00325
SMQGLCKFGFYEVFK

SLC25A3

131

Q00325
PGTDSGKVFCMFYAL

KCNK15

101

Q9H427
PSTDGGKVFCMFYAL

KCNK3

101

O14649
SLYFFLCGIMDGTKG

FANCM

381

Q8IYD8
CGRIYKDMFFSSGFQ

MAP3K6

356

O95382
VGDYFFGKCFDAMEV

ERAP1

396

Q9NZ08
SRVFVGDTFCYFAGM

DPAGT1

246

Q9H3H5
FCGIYSKDGQIFMSA

DCAF11

176

Q8TEB1
SIVYQKFPECGFFGM

PRKD3

91

O94806
KFPECGFFGMYDKIL

PRKD3

96

O94806
FKFAGMESGYACFCG

KREMEN1

156

Q96MU8
GKMFFVFCQESGYDT

GUCY1B1

71

Q02153
YFGAAATFRGIGMAC

MFSD6

596

Q6ZSS7
EGCYMCLFNTFGFGK

CD200

116

P41217
SACGGTFYMAEGIFN

CUBN

1736

O60494
FGVGYKMCTAFRTFD

ADAMTS3

486

O15072
FGDAMCKILSGFYYT

CCR1

101

P32246
KSGFGGITMLFTGYF

C17orf80

551

Q9BSJ5
RKFFMSGFTGYVPCA

FAM166B

176

A8MTA8
VFAMYALDKGFVTGG

EML6

906

Q6ZMW3
YMVFRFLCGFGISGI

SLC22A8

176

Q8TCC7
YCGLRFVAAFGMAGI

SLC22A11

196

Q9NSA0
GDGGLVCPYMEFFKN

IL1R1

136

P14778
GKFGGAFCRYADEMK

PURB

266

Q96QR8
GCFAQMYFILLFGGA

OR10A6

96

Q8NH74
LFGGAECFLLGAMAY

OR10A6

106

Q8NH74
GYVAMKFAQVFGCFF

SOAT1

321

P35610
SGGCSFAAIYIFMLF

SLC6A16

136

Q9GZN6
FDFLMSCVGYAIGLG

SLC6A1

51

P30531
FYIFSESYGGKMAAG

SCPEP1

161

Q9HB40
FFLIGFMIGYLGYCK

TFRC

76

P02786
FAKTELYGTGAMDFG

PIGW

156

Q7Z7B1
DLGFFGIYKGAKACF

SLC25A13

476

Q9UJS0
FAKMDPSCTVGFYAG

ATG4D

386

Q86TL0
LYFTAGFITGLGMCF

SLC16A5

106

O15375
FCYLMAQAGFGVYTK

SEC16A

1741

O15027
KDGVMCFGGRDYVFA

GTF2A1L

456

Q9UNN4
KFYTMCGLQEGFEPF

RYR3

1211

Q15413
CGGMFFFVSFEGKIV

PIEZO2

691

Q9H5I5
FFCGAFYLLGTGSMD

TRBV24-1

6

A0A075B6N3
AVCFVFMAGEVVGGY

SLC30A3

81

Q99726
KIIGQFGVGFYSAFM

TRAP1

196

Q12931
GVYFFSGKFGKCING

SCN11A

1196

Q9UI33
KKFFGEFTGFVDMCV

EFTUD2

421

Q15029
KFYGMFYKADHCVGG

MYO3B

86

Q8WXR4